Adrian Johnson

TLDR: Midwest medical firm HistoSonics secures $102m in Series D funding round led by Alpha Wave Ventures. The funding will be used to support the development and commercialization of the company’s non-invasive

Article Summary TLDR: – Although crypto firms raised nearly $3 billion in venture capital funding, we are not close to the levels seen in 2022. – PitchBook’s Senior Analyst Robert Le predicts

TLDR: Startups and venture capital are currently in a recession similar to 2008. Many VC-backed startups have gone out of business, with a significant increase in closures in the first quarter of

TLDR: The venture capital industry is experiencing a shift in fund dynamics between emerging managers and established funds. Larger, established funds are attracting more institutional capital while emerging managers face challenges in

TLDR: Venture capitalists are moving around more than usual, with notable figures returning to old firms, starting their own funds, or taking breaks from investing. Key figures include Lauri Moore joining Bessemer

TLDR: Multicoin Capital leads $3.5 million seed raise for Crunch Lab Crunch Lab, core contributor behind CrunchDAO, raised $3.5 million in seed funding led by Multicoin Capital. Start-up is a platform for

TLDR: HIPstr, the early-stage arm of HighPost, has raised $100 million for its debut fund. Limited partners include leading institutions, endowments, family offices, and high-net worth individuals. HighPost’s early-stage arm, HIPstr, has

TLDR: Chaos Labs, a leader in onchain risk management, secured a $55 million Series A funding round led by Haun Ventures to scale onchain economic security. The investment will support product development

Chaos Labs Raises $55M as Demand Grows for On-Chain Risk Management TLDR: New York crypto startup Chaos Labs raises $55 million in Series A funding led by Haun Ventures Chaos Labs focuses

TLDR: Dr. Leen Kawas discusses the evolution of biotechnology venture capital firms. Biotech venture capital firms provide funding and support to startup biotech companies. Dr. Leen Kawas, a seasoned biotech innovator and